High levels of multidrug resistance in clinical isolates of Gram-negative pathogens from Nigeria

International Journal of Antimicrobial Agents

Volumn 37, Issue 1, 2011, Pages 62-66

  Ogbolu, D O ^a,b,c   Daini, O A ^b   Ogunledun, A ^b   Alli, A O ^a   Webber, M A ^c  

^a LADOKE AKINTOLA UNIVERSITY OF TECHNOLOGY   (Nigeria)

^b OLABISI ONABANJO UNIVERSITY   (Nigeria)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

ESBL; Extended spectrum lactamase; Nigeria; Quinolone

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE AMPC; BETA LACTAMASE CTX M; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; MULTIDRUG RESISTANCE PROTEIN; NALIDIXIC ACID; OFLOXACIN; PEFLOXACIN; PROTEIN PARC; PROTEIN QEPA; PROTEIN QNRA; PROTEIN QNRB; PROTEIN QNRD; SPARFLOXACIN; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONFERENCE PAPER; CONTROLLED STUDY; ESCHERICHIA COLI; GENETIC VARIABILITY; GRAM NEGATIVE BACTERIUM; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NIGERIA; NONHUMAN; PRIORITY JOURNAL; PROTEUS; PSEUDOMONAS AERUGINOSA; SALMONELLA; SPECIES DIFFERENCE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; NIGERIA; PLASMIDS; PSEUDOMONAS;

EID: 78650297007     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.08.019     Document Type: Conference Paper

References (10)

1. G.A. Jacoby Mechanisms of resistance to quinolones Clin Infect Dis 41 Suppl. 2 2005 S120 S126
2. A. Robicsek, G.A. Jacoby, and D.C. Hooper The worldwide emergence of plasmid-mediated quinolone resistance Lancet Infect Dis 6 2006 629 640
3. D.M. Livermore, R. Canton, M. Gniadkowski, P. Nordmann, G.M. Rossolini, and G. Arlet CTX-M: changing the face of ESBLs in Europe J Antimicrob Chemother 59 2007 165 174
4. D.J. Eaves, E. Liebana, M.J. Woodward, and L.J. Piddock Detection of gyrA mutations in quinolone-resistant Salmonella enterica by denaturing high-performance liquid chromatography J Clin Microbiol 40 2002 4121 4125
5. C. Maynard, J.M. Fairbrother, S. Bekal, F. Sanschagrin, R.C. Levesque, and R. Brousseau Antimicrobial resistance genes in enterotoxigenic Escherichia coli O149:K91 isolates obtained over a 23-year period from pigs Antimicrob Agents Chemother 47 2003 3214 3221
6. A. Robicsek, J. Strahilevitz, D.F. Sahm, G.A. Jacoby, and D.C. Hooper qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States Antimicrob Agents Chemother 50 2006 2872 2874
7. J.M. Andrews BSAC Working Party on Susceptibility Testing ft BSAC standardized disc susceptibility testing method J Antimicrob Chemother 48 Suppl. 1 2001 43 57 [Erratum in: Antimicrob Chemother 2002;49:1049]
8. H. Derbyshire, G. Kay, K. Evans, C. Vaughan, U. Kavuri, and T. Winstanley A simple disc diffusion method for detecting AmpC and extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae J Antimicrob Chemother 63 2009 497 501
9. L.M. Cavaco, H. Hasman, S. Xia, and F.M. Aarestrup qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovis morbificans strains of human origin Antimicrob Agents Chemother 53 2009 603 608
10. I.E. Aibinu, V.C. Ohaegbulam, E.A. Adenipekun, F.T. Ogunsola, T.O. Odugbemi, and B.J. Mee Extended-spectrum β-lactamase enzymes in clinical isolates of Enterobacter species from Lagos, Nigeria J Clin Microbiol 41 2003 2197 2200